A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy - Tolosa - 2014 - Movement Disorders - Wiley Online Library
New drug, Tideglusib, approach moving to clinical trial shortly | Richard Weston's Myotonic Dystrophy Blog
Can Teeth Repair Themselves Without Fillings | Community Healthcare System
Tideglusib | C19H14N2O2S | CID 11313622 - PubChem
Tideglusib - Wikipedia
Positive results from myotonic dystrophy study | Muscular Dystrophy UK
Tideglusib = 98 HPLC 865854-05-3
Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β | SpringerLink
Tideglusib for Myotonic Dystrophy Clinical Trial 2023 | Power
Apexbio Technology LLC Tideglusib, 10mg. Cas: 865854-05-3 MFCD: MFCD18633296. | Fisher Scientific
Vijai Dental Depot Chennai - Researchers at King's College London have identified that Tideglusib can regenerate teeth from the inside out, possibly reducing the need for artificial fillings. The drug was previously
GSK3 Inhibitor-Induced Dentinogenesis Using a Hydrogel - A. Alaohali, C. Salzlechner, L.K. Zaugg, F. Suzano, A. Martinez, E. Gentleman, P.T. Sharpe, 2022
Tideglusib | ≥99%(HPLC) | GSK-3 Inhibitor | AdooQ®
The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells | SpringerLink
IJMS | Free Full-Text | Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis
Decline of the dentist's drill? Drug helps rotten teeth regenerate, trial shows | Stem cells | The Guardian
PDF) Tideglusib, a GSK-3 inhibitor, reduces progression of brain atrophy in progressive supranuclear palsy
IJMS | Free Full-Text | Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis
Tideglusib - Wikipedia
Promotion of natural tooth repair by small molecule GSK3 antagonists | Scientific Reports
Frontiers | GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis
Materials | Free Full-Text | Evaluating the Effect of Tideglusib-Loaded Bioactive Glass Nanoparticles as a Potential Dentine Regenerative Material
Therapeutic: tideglusib for congenital myotonic dystrophy
Tideglusib - an overview | ScienceDirect Topics
